Meta-analysisindependent cross-checkabstract checked★ key study I-EGG-113 in-depth review

Eating eggs does not raise TMAO in blood tests

Effect of egg consumption on circulating choline, betaine, and trimethylamine n-oxide in adults: a systematic review and meta-analysis of randomized controlled trials.

Overview

Aryaeian N et al.. Nutr J 2025 · PMID 41146117 · DOI 10.1186/s12937-025-01227-0

Pooled trials found no change in TMAO after egg consumption (WMD -0.08 umol/L).

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Test whether eggs raise TMAO.

How was the study done?

Meta-analysis of randomized trials.

How many people, animals or samples were studied?

5-6 RCTs.

What was actually found?

No effect on TMAO, choline or betaine.

How large was the observed effect?

TMAO WMD -0.08 (-0.47 to 0.32) umol/L.

What do the results mean in everyday life?

The 'eggs -> TMAO -> heart attack' chain breaks at its first step.

What are the study's limitations?

Few small trials.

What does it say about Elawady's specific claim?

Contradicts it.

Do the results apply to Germany and Europe?

Universal.

What can explicitly not be concluded from this study?

It cannot settle whether TMAO itself harms the heart.

Scientific in-depth review

1. Full reference

Authors
Aryaeian N et al.
Journal
Nutr J
Year
2025
Identifier
PMID 41146117 DOI 10.1186/s12937-025-01227-0
Verification
verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Authors declare no competing interests.

2. Research question

Does egg consumption change circulating choline, betaine and TMAO in adults?

3. Study design and population

Study design
Meta-analysis – Systematic review and meta-analysis of RCTs with NutriGRADE
Population

Adults in 6 RCTs (5 for TMAO)

Country

Multinational

Period

not stated in abstract

Sample size

6 RCTs

Inclusion and exclusion criteria

not detailed in abstract

4. Methods and endpoints

Exposure / intervention

Egg consumption

Comparator

Control diets

Endpoints

Plasma choline, betaine, TMAO

Statistical methods

Random-effects WMD; subgroup analyses; meta-regression; Egger/Begg tests; trim-and-fill

5. Actual results

Results

TMAO WMD -0.08 umol/L (95% CI -0.47 to 0.32; p = 0.692; I2 = 23%); choline WMD 0.10 (-0.92 to 1.12); betaine WMD 0.21 (-8.50 to 8.92). No publication bias for TMAO. NutriGRADE moderate certainty.

Absolute risks

not reported

Authors' conclusion

No clear effect of egg consumption on circulating choline, betaine or TMAO could be demonstrated.

6. Strengths

  • Only RCTs
  • Low heterogeneity for TMAO
  • Publication bias assessed

7. Weaknesses

  • Few, small, short trials

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Small number of trials; simplified judgement.

9. Assessment of the statistical interpretation

Even the upper CI (+0.32 umol/L) implies a negligible change in risk under the TMAO-mortality dose-response (stats/C-EGG-05_tmao.py).

10. Relevance to the specific claim

Directly tests the first link of the archive's chain (eggs -> TMAO): no effect in RCTs.

11. Independent contrary findings

Acute post-meal TMAO rises after eggs plus labelled phosphatidylcholine (A-EGG-13).

12. Transferability to Germany and Europe

Universal biology.

13. Overall methodological judgement

Key counter-evidence: eggs do not raise circulating TMAO in trials.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Long-term trials; people with kidney disease.

15. Linked fact checks